Your browser doesn't support javascript.
loading
Single-pill combination of cilnidipine, an l-/n-type calcium channel blocker, and valsartan reduces the day-by-day variability of morning home systolic blood pressure in patients with treated hypertension: A sub-analysis of the HOPE-combi survey.
Kario, Kazuomi; Matsuda, Saori; Nagahama, Shinobu; Kurose, Yoshiki; Sugii, Hitoshi; Teshima, Tsukasa; Suzuki, Noriyuki.
Afiliação
  • Kario K; Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
  • Matsuda S; Post-Marketing Medical Research Group, Medical Department, EA Pharma Co., Ltd., Tokyo, Japan.
  • Nagahama S; Post-Marketing Medical Research Group, Medical Department, EA Pharma Co., Ltd., Tokyo, Japan.
  • Kurose Y; Post-Marketing Medical Research Group, Medical Department, EA Pharma Co., Ltd., Tokyo, Japan.
  • Sugii H; Post-Marketing Surveillance, Mochida Pharmaceutical Co., Ltd., Tokyo, Japan.
  • Teshima T; Post-Marketing Surveillance, Mochida Pharmaceutical Co., Ltd., Tokyo, Japan.
  • Suzuki N; Medical Affairs Department, Mochida Pharmaceutical Co., Ltd., Tokyo, Japan.
J Clin Hypertens (Greenwich) ; 23(2): 392-397, 2021 02.
Article em En | MEDLINE | ID: mdl-33455076

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bloqueadores dos Canais de Cálcio / Hipertensão Tipo de estudo: Observational_studies Limite: Adult / Aged / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bloqueadores dos Canais de Cálcio / Hipertensão Tipo de estudo: Observational_studies Limite: Adult / Aged / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article